United States Antimony Corporation cash flow to debt ratio of -5.24K% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.

United States Antimony Corporation's free cash flow has decreased 2.20K% from $1.79M last year to $-37.50M, signaling decreasing performance

United States Antimony Corporation's debt to equity ratio is 0.00, which means that the company's assets are healthy financed, signaling financial stability.

United States Antimony Corporation's debt has decreased relative to shareholder equity from 0.06 last year to 0.00 today, signaling strengthened financials

United States Antimony Corporation has a net cash position, so leverage is healthy.

United States Antimony Corporation earns at least as much interest as it pays. Interest obligations are fully covered.

United States Antimony Corporation's profit margin has decreased (257.77%) in the last year from -11.58% to -41.44%, signaling decreasing performance

United States Antimony Corporation's short-term assets of $54.74M exceed its short-term liabilities of $10.18M

United States Antimony Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization

United States Antimony Corporation's return on equity of -16.94%, is lower than 15.00%, indicating bad performance

United States Antimony Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation

United States Antimony Corporation had positive net income in only 1 out of 5 years, indicating unstable earnings

United States Antimony Corporation has negative free cash flow, indicating the company is burning cash rather than generating it

United States Antimony Corporation has negative free cash flow, indicating cash burn

United States Antimony Corporation's yearly earnings has decreased 150.78% since last year from $-1.73M to $-4.34M, signaling decreasing performance

United States Antimony Corporation's yearly revenue has increased 162.80% since last year from $14.94M to $39.26M, signaling increasing performance

ROIC -12.11% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.

United States Antimony Corporation's 3-year revenue CAGR of 52.61% is positive, indicating growing revenue over the past 3 years

United States Antimony Corporation had revenue growth in 4 out of 5 years, indicating consistent revenue performance

United States Antimony Corporation had positive ROE in only 1 out of 5 years, indicating inconsistent returns on equity

United States Antimony Corporation has insufficient data to evaluate this check.

United States Antimony Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

United States Antimony Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model

United States Antimony Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable

United States Antimony Corporation is overvalued relative to its fair value price of -0.98 based on Earnings Fair Value model

United States Antimony Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails

United States Antimony Corporation has a price-to-book ratio of 7.16x, which exceeds the 5.00x threshold, indicating the stock may be overvalued relative to its book value

United States Antimony Corporation has a price-to-sales ratio of 24.19x, which exceeds the 8.00x threshold, indicating the stock may be overvalued relative to its revenue